Symbiox Investment & Trading Co Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
For the nine months, sales was INR 27.76 million compared to INR 36.08 million a year ago. Revenue was INR 29.8 million compared to INR 41.29 million a year ago. Net income was INR 2.36 million compared to INR 6.74 million a year ago. Basic earnings per share from continuing operations was INR 0.075 compared to INR 0.216 a year ago. Diluted earnings per share from continuing operations was INR 0.075 compared to INR 0.216 a year ago.